The KRAS gene is often mutated in cancer cells, and this mutation causes the cells to grow and spread indefinitely, resulting in the formation of tumors and aggravation of the disease. Adagrasib was developed to target this mutation and provide a new treatment option for lung cancer patients.
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: